HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 21.561 ↑ 0.77%
[as on 9 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 9 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 22.14% 0.77% -1.9% -5.22% 1.16% 23.21% 29.3%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -12.55% 0.92% -0.07% -4.11% -7.15% -12.96% 4.29% 9.78% 14.15% 13.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -8.94% 1.05% -0.59% -4.41% -4.88% -6.35% 7.49% 6.77% 11.93% 11.03%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 18.42% 0.62% -1.89% -5.71% -0.16% 16.2% 22.67% 17.55% 25.89% 14.38%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -3.67% 0.33% -0.88% -4.87% -5.88% -1.23% 11.67% 14.31% 18.67% 14.54%
SBI COMMA Fund - DIRECT PLAN - Growth -0.43% 0.03% -2.45% -8.18% -3.41% 3.4% 14.3% 8.62% 18.14% 14.07%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.38% -4.65% 6.99% -4.36% 7.84% 5.11% 6.59% 3.59% 3.8% -2.11%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.99%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.42% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.58%

Equity

NameSymbol / ISINSectorWeight %Other links
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.54%
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology8.94%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.08%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.06%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology4.04%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.94%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services3.84%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.70%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.48%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology3.24%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.23%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology3.10%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.06%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.85%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology2.82%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.37%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology2.34%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services2.25%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.24%
Jupiter Life Line Hospitals Limited (INE682M01020)Healthcare Services1.94%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology1.93%
Dr Reddys Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology1.90%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services1.90%
Molbio Diagnostics Limited (INE869T01028)Healthcare Equipment & Supplies1.77%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.73%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.61%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.60%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services1.39%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.31%
SYMBIOTEC PHARMALAB LIMITED**** (INE899I01028)Pharmaceuticals & Biotechnology1.21%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.18%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.09%
CORONA REMEDIES LIMITEDCORONA (INE02ZQ01018)Pharmaceuticals & Biotechnology1.07%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology1.06%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology0.85%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.57%
Novartis India Ltd.NOVARTIND (INE234A01025)Pharmaceuticals & Biotechnology0.47%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.38%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology0.34%
Portfolio data is as on date 31 August, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
9 October, 202621.561 0.77%
8 October, 202621.396 -2.37%
7 October, 202621.916 -0.33%
6 October, 202621.988 0.97%
5 October, 202621.777 -0.92%
1 October, 202621.979 0.16%
30 September, 202621.944 -2%
29 September, 202622.392 0.35%
28 September, 202622.315 -1.3%
25 September, 202622.61 -0.41%
24 September, 202622.702 -0.75%
23 September, 202622.873 0.81%
22 September, 202622.689 -0.89%
21 September, 202622.892 0.39%
18 September, 202622.803 1.15%
17 September, 202622.544 1.51%
16 September, 202622.208 -0.38%
15 September, 202622.292 -1.86%
11 September, 202622.714 -0.44%
10 September, 202622.814 0.29%
9 September, 202622.749 0.25%
8 September, 202622.692 0.92%
7 September, 202622.485 0.35%
4 September, 202622.406 -0.37%
3 September, 202622.49 0.24%
2 September, 202622.436 0.08%
1 September, 202622.418 -0.88%
31 August, 202622.618 0.48%
28 August, 202622.51 -0.04%
27 August, 202622.52

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 21.561 as on 9 October, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 22.14% as on 9 October, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 23.21% as on 9 October, 2026.
  • What are 3 year CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 3 year annualized returns (CAGR) of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 29.3% as on 9 October, 2026.
  • What are top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    Top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are:
    • Divis Laboratories Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Max Healthcare Institute Limited
    • Lupin Ltd.
    • Cipla Ltd.
    • Aster DM Quality Care Limited
    • Neuland Laboratories Limited
    • Anthem Biosciences Limited
    • Acutaas Chemicals Limited
    • Ipca Laboratories Ltd.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.